By vgreene, 22 June, 2015 Monitor ALT/AST, HBsAg, HBeAg, HBV DNA levels, and assess for cirrhosis annually [S/M]; exceptions:
By vgreene, 22 June, 2015 If confirmed or suspected antiviral resistance (hx of prior exposure or 1° nonresponse) to lamivudine, entecavir, adefovir or telbivudine, switch to tenofovir disoproxil [S/L]
By vgreene, 22 June, 2015 If HIV co-infxn, tx w/ tenofovir disoproxil + lamivudine (or emtricitabine) + efavirenz as a fixed-dose combo<sup>12</sup> [S/M]
By vgreene, 22 June, 2015 Monitor ALT/AST, HBsAg, HBeAg, HBV DNA levels, renal function<sup>11</sup> and adherence annually [S/M]; exceptions:
